| Literature DB >> 36014966 |
Marina Tesauro1,2, Mara Terraneo3, Michela Consonni1, Clara Fappani3,4, Daniela Colzani3, Caterina Stevanin3, Antonella Amendola2,3, Daniele Masseroni5, Elisabetta Tanzi2,3.
Abstract
During the COVID-19 public health emergency, an increasing number of studies reported the occurrence of SARS-CoV-2 in wastewaters worldwide, but little is known about the presence of the virus in surface freshwaters. The aim of the current study was to develop and validate an appropriate and scalable methodological approach for the concentration and detection of SARS-CoV-2 from surface freshwater samples, collected within the Milan rural network subjected to flood spillways activity. Overall, both surface water and distilled water samples spiked with inactivated SARS-CoV-2 were used to validate the concentration method for pathogens determination. Two pre-filtration systems, filter paper and Sartolab® P20 (Sartorius, Germany) and two concentration methods, two-phase (PEG-dextran method) separation and tangential flow ultrafiltration (UF), were compared. The effects of pre-filtration and concentration on viral nucleic acid recovery were assessed through real time RT-PCR targeting SARS-CoV-2 and the internal viral control PMMoV (Pepper Mild Mottle Virus). Our results showed that UF is more sensitive than the PEG-dextran method in viral acid nucleic recovery from surface water samples. Better results were obtained pre-filtering samples with Sartolab® P20 and extracting the nucleic acids with undiluted silica, rather than diluted as required by the standard protocol. The proposed method will be used for the monitoring of surface waters in the Milan area.Entities:
Keywords: SARS-CoV-2; flood spillways; surface freshwater
Year: 2022 PMID: 36014966 PMCID: PMC9415985 DOI: 10.3390/pathogens11080845
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Figure 1Flowchart of tests carried out on concentration methods, PEG-Dextran (P-D) method vs. tangential flow ultrafiltration (UF), starting from different types of water (distilled and freshwater) spiked with Inactivated SARS-CoV-2 Whole Virus (pellet).
Comparison between P-D and UF methods on distilled water and surface water spiked by inactivated SARS-CoV-2 (pellet). “NA” indicates not available data.
| Method | Sample | Distilled Water + Pellet | Surface Water + Pellet | ||||||
|---|---|---|---|---|---|---|---|---|---|
| SARS-CoV-2 | SARS-CoV-2 | ||||||||
| N1 | N2 | N1 | N2 | ||||||
| Mean gc/mL | Recovery% | Mean gc/mL | Recovery% | Mean gc/mL | Recovery% | Mean gc/mL | Recovery% | ||
|
| A: aliquot of | 74.53 | 85.55 | 72.13 | 65.93 | ||||
| C: concentrate after | 17.33 | 0.07% | <0.002 | NA | 27.09 | 0.25% | 23.43 | 0.25% | |
|
| D: aliquot of | 95.90 | 82.43 | 32.11 | <0.002 | ||||
| E: Vivaflow50 filtrate | <0.002 | <0.002 | <0.002 | <0.002 | |||||
| F: Vivaspin20 | 7470.01 | 31% | 6492.84 | 28% | 155.62 | 1.46% | 144.19 | 1.56% | |
| G: Vivaspin20 filtrate | <0.002 | <0.002 | <0.002 | <0.002 | |||||
| Inactivated SARS-CoV-2 Whole Virus (pellet) | 24,309.96 | 23,188.71 | 10,658.93 | 9219.12 | |||||
Comparison of methods in the pre-filtration step of the analyses. The second test was performed to compare no-prefiltration and pre-filtration with SARTOLAB methods. Not available data for pre-filtration with filter paper method are indicated with “NA”.
| Method | Sample | 1° TEST | 2° TEST | ||||||
|---|---|---|---|---|---|---|---|---|---|
| SARS-CoV-2 | SARS-CoV-2 | ||||||||
| N1 | N2 | N1 | N2 | ||||||
| Mean gc/mL | Recovery% | Mean gc/mL | Recovery% | Mean gc/mL | Recovery% | Mean gc/mL | Recovery% | ||
| K: sample as is | <0.002 | <0.002 | <0.002 | <0.002 | |||||
| X: contaminated sample | 225.90 | 208.73 | 165.65 | 102.33 | |||||
|
| D1: aliquot of | 229.15 | 199.09 | 145.69 | 136.75 | ||||
| E1: Vivaflow50 filtrate | <0.002 | <0.002 | <0.002 | <0.002 | |||||
| F1: Vivaspin20 | 423.04 | 1.92% | 311.25 | 1.44% | 1035.57 | 7.89% | 667.03 | 5.05% | |
| G1: Vivaspin20 filtrate | <0.002 | <0.002 | <0.002 | <0.002 | |||||
|
| D2: aliquot of | 234.72 | 102.09 | 115.48 | 96.37 | ||||
| Y: sample pre-filtered with SARTOLAB | 61.72 | 47.14 | 38.06 | 41.07 | |||||
| E2: Vivaflow50 filtrate | <0.002 | <0.002 | 10.37 | <0.002 | |||||
| F2: Vivaspin20 | 4970.19 | 22.50% | 3714.19 | 17.18% | 2289.82 | 17.44% | 2240.47 | 16.97% | |
| G2: Vivaspin20 filtrate | 45.44 | 51.36 | <0.002 | <0.002 | |||||
|
| D3: aliquot of | 236.23 | 173.33 | NA | NA | ||||
| P: filter paper + PBS | 164.48 | 181.93 | NA | NA | |||||
| Q: sample pre-filtered with filter paper | 411.79 | 336.57 | NA | NA | |||||
| E3: Vivaflow50 filtrate | 21.12 | <0.002 | NA | NA | |||||
| F3: Vivaspin20 concentrate | 1890.61 | 8.56% | 1992.98 | 9.22% | NA | NA | |||
| G3: Vivaspin20 filtrate | 88.01 | <0.002 | NA | NA | |||||
| Inactivated SARS-CoV-2 Whole Virus (pellet) | 22,086.04 | 21,619.99 | 13,131.30 | 13,201.91 | |||||
Experiments for implementing recovery of viral nucleic acids in surface water.
| Method | Sample | SARS-CoV-2 | |||
|---|---|---|---|---|---|
| N1 | N2 | ||||
| Mean gc/mL | Recovery% | Mean gc/mL | Recovery% | ||
|
| K1: sample as is | <0.002 | <0.002 | ||
| X1: contaminated | 345.26 | 197.42 | |||
| D1: aliquot of | 501.61 | 314.00 | |||
| Y1: sample pre-filtered with SARTOLAB | 174.90 | 69.90 | |||
| E1: Vivaflow50 filtrate | <0.002 | <0.002 | |||
| F1: Vivaspin20 | 5788.03 | 50.67% | 3492.95 | 40.49% | |
| G1: Vivaspin20 filtrate | <0.002 | <0.002 | |||
|
| K2: sample as is | <0.002 | <0.002 | ||
| X2: contaminated | 164.10 | 115.17 | |||
| D2: aliquot of | 529.11 | 299.32 | |||
| Y2: sample pre-filtered with SARTOLAB | 187.38 | 88.40 | |||
| E2: Vivaflow50 filtrate | <0.002 | <0.002 | |||
| F2: Vivaspin20 | 3239.85 | 28.36% | 2578.44 | 29.89% | |
| G2: Vivaspin20 filtrate | <0.002 | <0.002 | |||
| Inactivated SARS-CoV-2 Whole Virus (pellet) | 11,422.91 | 8627.16 | |||
Final experiments consisting of all the variables considered in the previous tests, in triplicate and in parallel.
| Method | Sample | SARS-CoV-2 | |||
|---|---|---|---|---|---|
| N1 | N2 | ||||
| Mean gc/mL | Recovery% | Mean gc/mL | Recovery% | ||
| K: sample as is (1 mL of 3 L) | <0.002 | <0.002 | |||
|
| A: aliquot of contaminated | 7.20 | 18.57 | ||
| C: concentrate after centrifugation | 25.22 | 0.85% | 20.11 | 0.96% | |
|
| D: aliquot of contaminated | 13.39 | 11.13 | ||
| Y: sample pre-filtered with | 5.82 | 9.99 | |||
| E: Vivaflow50 filtrate | <0.002 | <0.002 | |||
| F: Vivaspin20 concentrate | 66.66 | 2.26% | 50.50 | 2.41% | |
| G: Vivaspin20 filtrate | <0.002 | <0.002 | |||
| Inactivated SARS-CoV-2 Whole Virus (pellet) | 2951.78 | 2098.10 | |||
Figure 2Study domain: the rural canal, Roggia Gamberina, located in the south-west of the city of Milan (Italy). The numbers 1–9 indicate the location of the spillways (with the courtesy of D. Masseroni).
Primers and probes used for the molecular detection of SARS-CoV-2 and PMMoV RNA.
| Virus | Target Gene | Primer | Description | Sequence 5′-3′ | Reference |
|---|---|---|---|---|---|
| SARS-CoV-2 | N1 | 2019-nCoV_N1-F | 2019-nCoV_N1 Forward Primer | GACCCCAAAATCAGCGAAAT | [ |
| 2019-nCoV_N1-R | 2019-nCoV_N1 Reverse Primer | TCTGGTTACTGCCAGTTGAATCTG | |||
| 2019-nCoV_N1-P | 2019-nCoV_N1 Probe | FAM-ACCCCGCATTACGTTTGGTGGACC-BHQ1 | |||
| N2 | 2019-nCoV_N2-F | 2019-nCoV_N2 Forward Primer | TTACAAACATTGGCCGCAAA | ||
| 2019-nCoV_N2-R | 2019-nCoV_N2 Reverse Primer | GCGCGACATTCCGAAGAA | |||
| 2019-nCoV_N2-P | 2019-nCoV_N2 Probe | FAM-ACAATTTGCCCCCAGCGCTTCAG-BHQ1 | |||
| PMMoV | RdRp | PMMoV-F | PMMoV Forward Primer | GAGTGGTTTGACCTTAACGTTGA | [ |
| PMMoV-R | PMMoV Reverse Primer | TTGTCGGTTGCAATGCAAGT | |||
| PMMoV-P | PMMoV Probe | FAM-CCTACCGAAGCAAATG-BHQ_1 |